GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A(2A) Receptors

Glial cell line-derived neurotrophic factor (GDNF) affords neuroprotection in Parkinson’s disease in accordance with its ability to bolster nigrostriatal innervation. We previously found that GDNF facilitates dopamine release in a manner dependent on adenosine A(2A) receptor activation. Since motor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gomes, Catarina A.R.V., Simões, Patrícia F., Canas, Paula M., Quiroz, César, Sebastião, Ana M., Ferré, Sergi, Cunha, Rodrigo A., Ribeiro, Joaquim A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676206/
https://ncbi.nlm.nih.gov/pubmed/19141075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1471-4159.2009.05876.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller